Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to patents for its narcolepsy drug, Sunosi (solriamfetol). The settlement ...

Axsome Therapeutics has entered into a settlement agreement with Hikma resolving patent litigation related to Axsome’s product Sunosi (solriamfetol). The litigation, which is pending in the ...

A federal judge granted a joint request to drop Axsome Therapeutics Inc.'s patent claims against Hikma Pharmaceuticals Plc over proposed copies of Sunosi, leaving three generic-drug makers in the ...